Nutex Health EBITDA Margin 2016-2024 | NUTX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Nutex Health (NUTX) over the last 10 years. The current EBITDA margin for Nutex Health as of September 30, 2024 is .
| Nutex Health EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-09-30 | $0.29B | $0.01B | 3.42% |
| 2024-06-30 | $0.28B | $-0.00B | -0.36% |
| 2024-03-31 | $0.26B | $-0.01B | -2.70% |
| 2023-12-31 | $0.25B | $-0.01B | -5.24% |
| 2023-09-30 | $0.23B | $0.01B | 2.16% |
| 2023-06-30 | $0.20B | $-0.42B | -214.72% |
| 2023-03-31 | $0.20B | $-0.43B | -216.84% |
| 2022-12-31 | $0.22B | $-0.39B | -179.45% |
| 2022-09-30 | $0.31B | $-0.32B | -100.64% |
| 2022-06-30 | $0.40B | $0.18B | 45.54% |
| 2022-03-31 | $0.41B | $0.21B | 52.32% |
| 2021-12-31 | $0.33B | $0.18B | 53.61% |
| 2021-09-30 | $0.46B | $0.26B | 57.24% |
| 2021-06-30 | $0.34B | $0.19B | 55.33% |
| 2021-03-31 | $0.28B | $0.16B | 56.73% |
| 2020-12-31 | $0.27B | $0.16B | 58.24% |
| 2020-09-30 | $0.00B | $-0.00B | -100.00% |
| 2020-06-30 | $0.00B | $-0.00B | -400.00% |
| 2020-03-31 | $0.00B | $-0.01B | -600.00% |
| 2019-12-31 | $0.00B | $-0.01B | -600.00% |
| 2019-09-30 | $0.00B | $-0.00B | -300.00% |
| 2019-06-30 | $0.00B | $-0.00B | -200.00% |
| 2019-03-31 | $0.00B | $-0.00B | -100.00% |
| 2018-12-31 | $0.00B | 0 | 0.00% |
| 2018-09-30 | $0.00B | $-0.00B | inf% |
| 2018-06-30 | $0.00B | $-0.00B | inf% |
| 2018-03-31 | $0.00B | $-0.01B | inf% |
| 2017-12-31 | $0.00B | $-0.01B | inf% |
| 2016-03-31 | $0.00B | 0 | nan% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.359B | $0.248B |
| Nutex Health Inc. is a physician-led, technology-enabled healthcare services company. The Company's operating divisions include Hospital division and Population Health Management division. Hospital division implements and operates different health care models, including micro hospitals, specialty hospitals and hospital outpatient departments. Population Health Management division owns and operates provider networks such as Independent Physician Associations. Nutex Health Inc., formerly known as Clinigence Holdings Inc., is based in HOUSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $149.005B | 27.54 |
| Elevance Health (ELV) | United States | $90.276B | 11.81 |
| CVS Health (CVS) | United States | $82.998B | 12.15 |
| Cencora (COR) | United States | $47.050B | 17.08 |
| DiDi Global (DIDIY) | China | $24.788B | 0.00 |
| Natera (NTRA) | United States | $22.891B | 0.00 |
| ICON (ICLR) | Ireland | $15.361B | 13.68 |
| Doximity (DOCS) | United States | $14.388B | 74.82 |
| BioMerieux (BMXMF) | France | $13.819B | 0.00 |
| Revvity (RVTY) | United States | $13.662B | 22.91 |
| Viatris (VTRS) | United States | $12.891B | 3.97 |
| Solventum (SOLV) | United States | $12.825B | 0.00 |
| Avantor (AVTR) | United States | $12.168B | 17.87 |
| CochLear (CHEOY) | Australia | $11.076B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.364B | 26.93 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.228B | 0.00 |
| HealthEquity (HQY) | United States | $9.766B | 49.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.787B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.772B | 15.02 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.784B | 26.90 |
| Organon (OGN) | United States | $3.935B | 4.01 |
| BrightSpring Health Services (BTSG) | United States | $3.839B | 81.67 |
| Sotera Health (SHC) | United States | $3.818B | 20.42 |
| Surgery Partners (SGRY) | United States | $3.288B | 37.49 |
| Concentras Parent (CON) | United States | $2.893B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.622B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.467B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.108B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.097B | 0.00 |
| PACS (PACS) | United States | $2.041B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.921B | 50.40 |
| Progyny (PGNY) | United States | $1.904B | 38.55 |
| Premier (PINC) | United States | $1.623B | 10.39 |
| Agilon Health (AGL) | United States | $1.409B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| CareDx (CDNA) | United States | $1.314B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.207B | 11.81 |
| Establishment Labs Holdings (ESTA) | $1.010B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.892B | 6.04 |
| Embecta (EMBC) | United States | $0.863B | 5.92 |
| Auna S.A (AUNA) | Luxembourg | $0.639B | 0.00 |
| DocGo (DCGO) | United States | $0.565B | 21.31 |
| SBC Medicals (SBC) | United States | $0.492B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.486B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.458B | 0.00 |
| MultiPlan (MPLN) | United States | $0.446B | 0.00 |
| Enhabit (EHAB) | United States | $0.437B | 37.83 |
| QDM (QDMI) | Hong Kong, SAR China | $0.421B | 11.03 |
| LifeMD (LFMD) | United States | $0.332B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.313B | 0.00 |
| Beauty Health (SKIN) | United States | $0.207B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.181B | 0.00 |
| Biodesix (BDSX) | United States | $0.143B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.136B | 0.00 |
| So-Young (SY) | China | $0.112B | 19.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.090B | 0.00 |
| ModivCare (MODV) | United States | $0.084B | 4.57 |
| IceCure Medical (ICCM) | Israel | $0.075B | 0.00 |
| Oncology Institute (TOI) | United States | $0.073B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| Singular Genomics Systems (OMIC) | United States | $0.051B | 0.00 |
| OncoCyte (OCX) | United States | $0.045B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.022B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.017B | 0.00 |
| KindlyMD (KDLY) | United States | $0.017B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |